Novo Integrated Sciences PE Ratio 2012-2024 | NVOS
Current and historical p/e ratio for Novo Integrated Sciences (NVOS) from 2012 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Novo Integrated Sciences PE ratio as of November 11, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Novo Integrated Sciences PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2024-11-05 |
0.15 |
|
0.00 |
| 2024-05-31 |
1.05 |
$-1.18 |
0.00 |
| 2024-02-29 |
0.63 |
$-0.54 |
0.00 |
| 2023-11-30 |
1.20 |
$-0.98 |
0.00 |
| 2023-08-31 |
0.14 |
$-1.90 |
0.00 |
| 2023-05-31 |
0.13 |
$-9.50 |
0.00 |
| 2023-02-28 |
0.13 |
$-10.70 |
0.00 |
| 2022-11-30 |
0.25 |
$-11.80 |
0.00 |
| 2022-08-31 |
1.67 |
$-11.30 |
0.00 |
| 2022-05-31 |
2.05 |
$-4.50 |
0.00 |
| 2022-02-28 |
1.39 |
$-3.40 |
0.00 |
| 2021-11-30 |
1.44 |
$-2.30 |
0.00 |
| 2021-08-31 |
1.82 |
$-1.60 |
0.00 |
| 2021-05-31 |
2.22 |
$-0.80 |
0.00 |
| 2021-02-28 |
5.21 |
$-0.60 |
0.00 |
| 2020-11-30 |
0.36 |
0 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.001B |
$0.013B |
|
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
|
